Muscarinic M1, M2 receptor binding. Relationship with functional efficacy

Area of Science:

• Pharmacology
• Neuroscience
• Biochemistry

Background:

• Muscarinic receptors are crucial in the central nervous system and periphery.
• Differentiating between M1 and M2 receptor subtypes is essential for understanding their distinct functions.
• Previous studies have explored selective ligands, but a comprehensive comparison of agonist and antagonist profiles is needed.

Purpose of the Study:

• To compare the selectivity of various muscarinic agents for M1 and M2 receptors.
• To investigate how intrinsic activity and affinity states influence agonist and antagonist binding profiles.
• To determine if muscarinic agents can distinguish between receptor subtypes and affinity states in different tissues.

Main Methods:

• Radioligand binding assays were performed using [3H]pirenzepine for M1 receptors in rat cerebral cortex.
• [3H]N-methylscopolamine was used for M2 receptors in rat cardiac membranes.
• Binding affinities and selectivity of various muscarinic antagonists and agonists were evaluated.

Main Results:

• Several antagonists, including trihexyphenidyl HCl and benztropine, showed M1 selectivity.
• Dicyclomine and hexahydrosiladifenidol exhibited selectivity comparable to pirenzepine.
• Gallamine and AFDX-116 were identified as M2-selective antagonists.
• Muscarinic agonists clustered into two groups based on apparent tissue selectivity, linked to intrinsic activity (full vs. partial agonists).

Conclusions:

• Muscarinic agents can distinguish between M1 and M2 receptor populations.
• Intrinsic activity of muscarinic agonists influences their apparent selectivity profiles.
• Agonist binding can reflect recognition of high and low affinity states, not solely true receptor selectivity.